At the world's largest medical trade fair, Medica 2011 held in Düsseldorf last week, CardioComm Solutions, Inc. (TSX-V: EKG) demonstrated their newly developed remote patient ECG monitoring service, called HeartCheckTM Smart Monitoring (Smart Monitoring). Smart Monitoring uses CardioComm's new application programming interface (API), and their established C4™ (CardioComm Coordinating Centre) arrhythmia and ECG management service to interact with handheld patient-activated ECG monitoring devices.
How the Solution Works
CardioComm Solutions' new API works specifically with the FDA-cleared and CE-certified HeartCheck™ ECG monitor. The HeartCheckTM ECG monitor functions as an arrhythmia as well as a resting ECG monitor, providing a function much like a digital thermometer for the heart. Other such devices may connect via cell phone or over the internet, and enable individuals to record and store their ECGs, but the critical question often asked is who will review these ECGs and how?
"At CardioComm," said CEO Etienne Grima, "we've developed FDA-cleared and CE-approved solutions to answer these two questions. We can transmit these ECGs under a standardized format in such a manner that physicians have rapid access to review them and provide a medical interpretation or recommendation for how patients should proceed.
"Using a handheld ECG device is not new," added Grima. "What is new is that with our proven C4 technology, patients now have the unique capacity to securely connect over the internet and within minutes have their ECGs accessed by physicians from anywhere in the world. The significance of this is the existence of a large population of consumers with chronic conditions (the 3C market) who own or wish to purchase devices that can assist in monitoring their heart health."
Medica Demo
At Medica 2011, CardioComm demonstrated the interoperability between C4 and the handheld ECG monitor to several companies, recording ECGs while at the congress in Germany and transmitting them to CardioComm's server facilities in Canada. The ECG recordings were then reviewed within minutes through the physician portal for C4.
"The responses we received at Medica were very enthusiastic," said Grima, "and we anticipate future opportunities to integrate our C4 software service as a preferred back-end ECG management solution with several devices. We intend to develop a virtual server support system in different countries in order to adhere to those countries' requirements for the control of personal health records.
"At CardioComm, we're committed to being a preferred solution for everything that is ECG, and to address the 3C market," said Grima. "We continue to develop new products and services, many of which will be released in 2012, including expansion of our traditional PC- and LAN-based solutions that will be Window 7 and Windows Server 2008 compatible."
This solution marks CardioComm's second successful launch of an internationally-accessible ECG management solution. The first was the release of CardioComm's FDA-cleared Global Cardio 12-lead solution (GC12). GC12 enables remote recording of ECGs up to a 12-lead configuration from any location, and with physician access to these ECGs over the internet. The applicability of GC12 is limitless and includes in-hospital, satellite clinic, and in-ambulance monitoring.
CRISPR-based therapy shown to be safe, effective for people with transthyretin amyloidosis